Tumour Suppressing Agents

Tumour Suppressing Agents

Tumour suppressing agents are a class of drugs that are used in the treatment of cancer. These agents work by inhibiting the growth and spread of cancer cells, and are often used in combination with other therapies such as chemotherapy and radiation therapy. Tumour suppressing agents are also known as anti-cancer agents or anti-neoplastic agents. One of the most common types of tumour suppressing agents is the chemotherapy drug, cisplatin. This drug works by binding to the DNA in cancer cells, preventing them from dividing and growing. Other tumour suppressing agents include methotrexate, which inhibits the production of DNA, and tamoxifen, which blocks the action of estrogen in breast cancer cells. Tumour suppressing agents are typically administered intravenously or orally, and may be given in cycles to allow healthy cells to recover between treatments. These drugs can cause a range of side effects, including nausea, vomiting, hair loss, and fatigue. However, the benefits of these drugs in treating cancer often outweigh the risks of side effects. In addition to chemotherapy drugs, other types of tumour suppressing agents include targeted therapies, which are designed to specifically target cancer cells while sparing healthy cells. Examples of targeted therapies include monoclonal antibodies, which bind to specific proteins on cancer cells, and tyrosine kinase inhibitors, which block the action of enzymes that promote cancer cell growth. Overall, tumour suppressing agents are an important class of drugs in the treatment of cancer. While they can cause side effects, they offer hope to patients with cancer by inhibiting the growth and spread of cancer cells.

chemotherapy, cisplatin, methotrexate, tamoxifen, targeted therapies

— Christopher Jones